Practice Quiz

FPGEE Foreign Pharmacy

Category - Clinical

Start a Study Session Sign up for Question of the Day
A patient is newly diagnosed with rheumatoid arthritis. What is the current recommendation for the use of DMARDs (Disease Modifying Anti-Rheumatic Drugs)?
  1. DMARDs are used as a drug regimen of “last resort.”
  2. DMARDs should only be initiated after monoclonal antibody treatment has been unsuccessful.
  3. DMARDs are ineffective.
  4. DMARDs should be begun within 3 months of diagnosis.
Explanation
Answer: D − The current recommendation is that DMARDs be initiated within 3 months of diagnosis. DMARDs are a broad class of drugs and encompass a variety of drugs such as biologics, immunosuppressants, and the antimalarial drug hydroxychloroquine.
Was this helpful? Upvote!
Login to contribute your own answer or details
Start a Study Session Sign up for Question of the Day

Top questions

Related questions

Most popular on PracticeQuiz